Acceleron Pharma
(XLRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XLRN | RNA | QGEN | ||
| Company | Acceleron Pharma | Avidity Biosciences Inc | Qiagen N.V. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 179.85 | 73.00 | 51.16 | ||
| High | 179.85 | 73.01 | 51.60 | ||
| Low | 177.06 | 72.87 | 50.71 | ||
| Latest | 178.75 | 72.91 | 50.85 | ||
| Change | -0.93 | -0.01 | -0.21 | ||
| % Change | -0.52% | -0.01% | -0.41% | ||
| Volume | 7,884,200 | 3,467,500 | 1,472,000 | ||
| 20-Day Average Volume | 1,302,050 | 2,079,760 | 3,609,870 | ||
| Previous Close | 179.68 | 72.92 | 51.06 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 174.46 | 72.71 | 52.42 | ||
| 20-Day Raw Stochastic | 84.01% | 77.27% | 40.70% | ||
| 20-Day Relative Strength | 70.12 | 69.58 | 50.28 | ||
| Weighted Alpha | +57.78 | +86.50 | +17.99 | ||
| Today's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.26% since 11/12/21 | +0.12% since 02/05/26 | -0.74% since 02/05/26 | ||
| Low | 173.17 on 11/16/21 | 72.68 on 02/11/26 | 50.53 on 02/09/26 | ||
| High | 179.94 on 11/17/21 | 73.01 on 02/12/26 | 51.71 on 02/10/26 | ||
| 1-Month | |||||
| %Chg | +2.88% since 10/19/21 | +0.77% since 01/12/26 | +7.62% since 01/12/26 | ||
| Low | 172.25 on 10/20/21 | 72.32 on 01/13/26 | 46.07 on 01/20/26 | ||
| High | 179.94 on 11/17/21 | 73.06 on 02/03/26 | 57.81 on 01/20/26 | ||
| 3-Month | |||||
| %Chg | +48.97% since 08/19/21 | +2.95% since 11/12/25 | +8.48% since 11/12/25 | ||
| Low | 120.20 on 08/20/21 | 70.42 on 11/20/25 | 45.88 on 11/18/25 | ||
| High | 189.99 on 09/29/21 | 73.06 on 02/03/26 | 57.81 on 01/20/26 | ||
| 6-Month | |||||
| %Chg | +44.53% since 05/19/21 | +57.71% since 08/12/25 | -1.35% since 08/12/25 | ||
| Low | 113.49 on 07/15/21 | 35.70 on 09/11/25 | 45.07 on 11/07/25 | ||
| High | 189.99 on 09/29/21 | 73.06 on 02/03/26 | 57.81 on 01/20/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,931,634 | 11,283,641 | 10,782,646 | ||
| Shares Outstanding, K | 61,156 | 154,740 | 211,176 | ||
| Annual Sales | 92,520,000 | 10,900,000 | 2,090,000,000 | ||
| Annual Net Income | -166,030,000 | -322,300,000 | 424,880,000 | ||
| Last Quarter Sales | 34,200,000 | 12,480,000 | 540,420,000 | ||
| Last Quarter Net Income | -70,470,000 | -174,440,000 | 107,830,000 | ||
| 60-Month Beta | 0.13 | 0.93 | 0.67 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.16 on 11/04/21 | -1.27 on 11/10/25 | 0.62 on 02/04/26 | ||
| Latest Earnings Date | 02/24/22 | 02/26/26 | 05/06/26 | ||
| Most Recent Dividend | N/A | N/A | 0.250 on 07/02/25 | ||
| Next Ex-Dividends Date | N/A | N/A | 07/02/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 20.66 | ||